期刊文献+

重组人血小板生成素治疗非小细胞肺癌化疗后血小板减少的临床观察 被引量:1

下载PDF
导出
摘要 血小板减少是恶性肿瘤化疗的常见不良反应之一。它的发生限制了化疗药物的剂量,影响了化疗疗效,而且严重血小板减少的患者有自发性出血的倾向,可能危及患者生命。重组人血小板生成素(recombinant human thrombopoietin,rhTPO)为近年来开发的一种促血小板生长因子,研究表明,
出处 《临床荟萃》 CAS 2011年第11期984-985,共2页 Clinical Focus
  • 相关文献

参考文献3

二级参考文献12

  • 1Murray LJ, Luens KM, Estrada MF, et al. Thrombopoietin mobilizes CD34 + cell subsets into peripheral blood and expands muhilineage progenitors in bone marrow of cancer patients with normal hematopoiesis [J]. Exp Hematol, 1998, 26(3) :207. 被引量:1
  • 2Vadhan RS. Recombinant human thrombopoietin in myelosuppressive chemotherapy [J]. Oncology (Huntingt) ,2001, 15(7 Suppl 8) :35. 被引量:1
  • 3Vadhan RS, Murray LJ, Bueso RC, et al. Stimulation of megakaryocyte and platelet production by a single dose of recombinant human thrombopoietin in patients with cancer [J]. Ann Intern Med, 1997,126(9) :673. 被引量:1
  • 4Kaushansky K,Lok S,Holly RD,et al.Promotion of megaka-ryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin[J].Nature,1994,369:568~571. 被引量:1
  • 5Borge OJ,Ramsfjell V,Veiby OP,et al.Thrombopoietin,but not erythropoietin promotes viability and inhibits apoptosis of multipotent murinehematopoietic progenitor cells in vitro[J].Blood,1996,88:2859~2870. 被引量:1
  • 6David J,Kuter and C,Glenn Begley.Recombinant human thrombopoietin:basic biology and evalution of clinical studies[J].Blood,2002,100(10):3457~3469. 被引量:1
  • 7Archimbaud E,Ottmann OG,Yin JA,et al.A randomized,double-blind,placebo-controlled study with pegylated recombinant human megakaryocyte growth and development factor(PEG-rHuMGDF) as an adjunct to chemotherapy for adults with de novo acute myeloid leukemia[J].Blood,1999,94:3694~3701. 被引量:1
  • 8Nash R,Kurzrock R,Dipersio J,et al.Safety and activity of recombinant human thrombopoietin (rhTPO) in patients(pts) with delayed platelet recovery(DPR)[J],Blood,1997,90:262a. 被引量:1
  • 9Von dem BA,Folman C,linthorst G,et al.The potential role of thrombopoietin in idiopathic thrombocytopenic purpura[J].Blood Rev,2002,16(1):57~59. 被引量:1
  • 10Dan K,Nomura S,Hotta T,et al.Biological effect of pegylated recombinant human megakaryocyte growth and development factor(PEG-rHuMGDF) in patients with idiopathic thrombocytopenic purpura[J].Blood,2001,98:299. 被引量:1

共引文献53

同被引文献20

引证文献1

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部